Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Hospitals and Health Systems market: $1,829.7 Bn against $350.2 Bn in 2023, about 5.2 times as large.
China grows faster: 7.1% a year, against 3.6%. The gap still grows from $1,479.5 Bn to $1,910.6 Bn by 2033.
Clinical research: 12,857 active trials in the US, 16,458 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $1,829.7 Bn | $350.2 Bn |
| Market size, 2033 projected | $2,606 Bn | $695.4 Bn |
| Growth a year (CAGR) | 3.6% | 7.1% |
| Money added, 2023–2033 | $776.3 Bn | $345.2 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $5,353 | $249 |
| Active clinical trials | 12,857 | 16,458 |
| Universal health coverage index index (0–100) (WHO) | 88 2023 | 85 2023 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Hospitals and Health Systems market: $1,829.7 Bn against $350.2 Bn in 2023, about 5.2 times as large.
China grows faster: 7.1% a year, against 3.6%. The gap still grows from $1,479.5 Bn to $1,910.6 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Health figures: WHO. Population: World Bank.